Organogenesis Holdings Inc. Class A Common Stock
ORGO Real Time Price USDRecent trades of ORGO by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by ORGO's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Oral tissue regeneration and repair Oct. 10, 2017
-
Patent Title: Tissue repair fabric Mar. 22, 2011
-
Patent Title: Method and apparatus for inducing controlled mechanical constraints in a tissue construct Mar. 15, 2011
-
Patent Title: Bioengineered tissue constructs and methods for producing and using thereof Nov. 02, 2010
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of ORGO in WallStreetBets Daily Discussion
Recent insights relating to ORGO
Recent picks made for ORGO stock on CNBC
ETFs with the largest estimated holdings in ORGO
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view ORGO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.